Gitnux/Report 2026

Consumer Genomics Industry Statistics

The global consumer genomics market reached an estimated $4.17 billion in 2025, explore the figures behind growth, company scale, and subscription-driven trends.
19Statistics
31Sources
3Sections
1Visuals
15mRead
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 44 days

01 Industry overview

The consumer genomics industry at a glance

The global consumer genomics market reached an estimated $4.17 billion in 2025, with North America the largest regional market and demand shifting toward personalized health, ancestry and subscription-based services.

$4.17B[2]
Global market size, 2025
21.2%[2]
Forecast CAGR, 2025–2030
29M[13]
AncestryDNA customers, 2025
$305M[14]
23andMe asset acquisition, 2025
Market size
The global consumer genomics market was estimated at $4.17 billion in 2025. A separate estimate put the market at $2.39 billion in 2025, reflecting differing definitions of consumer genomics and market boundaries.[2][15]
Forecast & CAGR
The Business Research Company forecasts growth from $4.17 billion in 2025 to $10.86 billion in 2030, equivalent to a 21.2% CAGR. Mordor Intelligence estimates a higher 23.95% CAGR from 2026 to 2031, reaching $8.66 billion.[2][15]
Market share & regions
North America was the largest regional market in 2025, while Asia-Pacific was identified as the fastest-growing region. A reliable current percentage split by region was not available in the public sources reviewed.[2]
Segmentation
Consumer genomics products span ancestry and genetic relatedness, health-risk and diagnostic reports, sports nutrition, nutrition and wellness, and pharmacogenomic applications. Genetic relatedness was the largest application segment in Grand View Research’s latest publicly available breakdown, with a 19.8% revenue share in 2022.[4][16]
Key players & concentration
Leading companies include Ancestry, 23andMe, MyHeritage, Gene by Gene, Color Genomics, Helix, Mapmygenome and Veritas Genetics. Ancestry reported 29 million AncestryDNA customers at the end of 2025, while 23andMe reported 15.1 million customers as of September 30, 2024; comparable current market-share percentages were not publicly disclosed.[13][17]
Trends, drivers & challenges
Growth is being supported by demand for personalized medicine, falling genotyping and sequencing costs, broader online distribution, and the addition of recurring health and genealogy subscriptions. Key challenges include the need to confirm many consumer-test results clinically, privacy and cybersecurity risks, and uncertainty over the clinical utility of some reports.[2][18][19]
Consumer behavior & competition
Ancestry reported more than 3.8 million subscribers and 29 million AncestryDNA customers at the end of 2025, indicating the importance of combining one-time DNA testing with recurring genealogy subscriptions. Competition is increasingly based on database scale, relative matching, interpretation updates, privacy controls and health-report breadth.[13]
M&A
On July 14, 2025, 23andMe completed the sale of substantially all of its assets to 23andMe Research Institute, formerly TTAM Research Institute, for $305 million in cash. The transaction included the Personal Genome Service, Research Services and Lemonaid Health businesses.[14][20]
Regulation
In the United States, the FDA requires direct-to-consumer tests to be analytically valid, clinically valid and appropriate for use without a healthcare professional when applicable. MedlinePlus advises that consumer results generally require confirmation through additional provider-ordered testing before diagnostic or treatment decisions are made.[19][18]
Latest news
The most significant recent industry development was the completion of 23andMe’s $305 million asset sale to 23andMe Research Institute on July 14, 2025, following the company’s court-supervised bankruptcy process. Ancestry’s 2025 impact report, published April 21, 2026, reported 29 million AncestryDNA customers and more than 3.8 million subscribers at year-end 2025.[14][13]

02 Ranking

Top 9 Companies in the Consumer Genomics Industry

The leading companies in the consumer genomics industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 18, 2026 · Next review December 18, 2026

Verdict

Ancestry stands out for consumer ancestry DNA scale because AncestryDNA reached 29 million customers at the end of 2025, while GenePlanet focuses on preventive genetic tests and consumer lifestyle insights since it develops preventive genetic tests and consumer analyses for health and lifestyle insights.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in ancestry DNA testing

    Ancestry

    US

    Ranked #1 · 9.2 · Ancestry DNA testing

    Why we picked it: Its consumer ancestry DNA base pairs with recurring genealogy subscriptions, supporting ongoing report updates.

  2. Leader in health and wellness reports

    GenePlanet

    SI

    Ranked #2 · 8.8 · Health and wellness reports

    Why we picked it: Its focus stays on preventive testing and lifestyle interpretation for European consumers.

  3. Leader in pharmacogenomics testing

    myDNA

    AU

    Ranked #4 · 8.5 · Pharmacogenomics testing

    Why we picked it: It combines pharmacogenomics, wellness, and genealogy following the two genomics acquisitions.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 9 companies in the consumer genomics industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Ancestry

Ancestry DNA testing · US

9.2
2

GenePlanet

Health and wellness reports · SI

8.8
3

23andMe Research Institute

Health and wellness reports · US

8.5
4

myDNA

Pharmacogenomics testing · AU

8.5
5

Prenetics

Health and wellness reports · HK

8.4
6

Dante Labs

Consumer whole-genome sequencing and health reports · US

8.3
7

tellmeGen

Consumer health, pharmacogenomics and ancestry · ES

8.1
8

African Ancestry

African lineage ancestry testing, global diaspora · US

8.1
9

Living DNA

Consumer ancestry and wellbeing genomics, global · GB

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 18, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 19). Top 9 companies in the consumer genomics industry. In Consumer Genomics Industry Statistics. Gitnux. https://gitnux.org/consumer-genomics-industry-statistics/#top-companies

report visual · Projection

United States direct-to-consumer genetic testing market size

United States direct-to-consumer genetic testing market size fell from $2.4B in 2021 to $1.9B in 2024.

$2.4B
Start
-7.49%
CAGR · 3y
$1.9B
Projected
20212024
source-verifiedgminsights.com2024

04 Statistics

Market Intelligence

Market sizing varies by definition, with a $4.17 billion 2025 estimate alongside $2.39 billion. Growth forecasts include a 21.2% CAGR from 2026 to 2030.

Market size and service revenue in the consumer genomics industry

  • $2.25 billion in 2025 for the global consumer genomics market, defined across ancestry, health, wellness and consumer testing services.[1]
  • $4.17 billion in 2025 for the global consumer genomics market, defined as revenue across product, technology and application segments.[2]
  • $3.90 billion in 2024 for the global consumer genomics market, covering genetic testing kits and genomic data-analysis services.[3]
  • $2.90 billion in 2026 for the global consumer genomics market, covering genetic relatedness, ancestry, diagnostics, sports nutrition and health applications.[4]
  • $4.38 billion in 2025 for the global consumer genomics market, covering consumer genomic testing and related services.[5]
  • $2.45 billion in 2025 for the global consumer genomics market, covering direct-to-consumer testing, health, wellness and ancestry applications.[6]

Growth forecasts for the consumer genomics industry

  • 15.6% CAGR is projected for the global consumer genomics market from 2025 to 2030, reaching more than $9.3 billion; published in 2025.[3]
  • 14% CAGR is projected for the global predictive genetic testing and consumer genomics market from 2025 to 2034, reaching $27.1 billion; published in 2025.[7]
  • 24.8% CAGR is projected for the global consumer genomics market from 2023 to 2030, reaching $7.2 billion; published in 2023.[4]
  • 21.2% CAGR is projected for the global consumer genomics market from 2026 to 2030, reaching $10.86 billion; published in 2026.[2]

05 Statistics

Pricing

Package pricing spans $29–$259 for 1Health.io direct-to-consumer DNA tests in the United States. Reviews in 2026 show consult add-ons across observed providers.

Fees and price levels in the consumer genomics industry

  • $29–$259 was the package-price range reported for 1Health.io’s direct-to-consumer DNA health, wellness and ancestry tests in the United States.[8]
  • 33 of 55 direct-to-consumer nutrigenetic companies charged extra for individual consultations in the review’s observed sample of online providers, published in 2026.[9]
  • 14 of 55 direct-to-consumer nutrigenetic companies included individual consultations in the test price in the review’s observed sample of online providers, published in 2026.[9]

06 Statistics

Risk & Compliance

Recent enforcement centers on genetic data protection after breaches, including $18 million secured from 23andMe by New York and 42 attorneys general after the 2023 breach.

Client data and confidentiality in the consumer genomics industry

  • $18 million was secured from 23andMe by New York and 42 other attorneys general over failure to protect customers’ private genetic data after the 2023 breach.[10]
  • £2.31 million was the Information Commissioner’s Office penalty imposed on 23andMe for failing to protect UK users’ genetic data under UK data-protection law.[11]
  • 319,635 Canadian customers were affected by the 23andMe breach, according to the joint 2025 investigation by Canada’s Privacy Commissioner and the UK Information Commissioner.[12]

Incidents, safety and loss events in the consumer genomics industry

  • 4,364 additional 23andMe customer accounts were compromised during a second intense credential-stuffing period in September 2023.[12]
  • 305,245 New York consumers were among the 6.9 million people affected by 23andMe’s October 2023 data breach.[10]
  • 18,222 23andMe customer accounts were accessed worldwide during the credential-stuffing attack between April 29 and September 20, 2023.[12]

Key questions about the consumer genomics industry

What is the global consumer genomics market size in 2025?
The global consumer genomics market reached an estimated $4.17 billion in 2025. A separate estimate put the market at $2.39 billion in 2025, reflecting differing definitions of consumer genomics and market boundaries.
How fast is the consumer genomics market forecast to grow?
The Business Research Company forecasts growth from $4.17 billion in 2025 to $10.86 billion in 2030, equivalent to a 21.2% CAGR. Mordor Intelligence estimates a higher 23.95% CAGR from 2026 to 2031, reaching $8.66 billion.
Which companies lead the consumer genomics industry?
Ancestry stands out for consumer ancestry DNA scale because AncestryDNA reached 29 million customers at the end of 2025, while GenePlanet focuses on preventive genetic tests and consumer lifestyle insights since it develops preventive genetic tests and consumer analyses for health and lifestyle insights.
What technology and delivery shifts are shaping consumer genomics in this period?
Growth is supported by falling genotyping and sequencing costs and broader online distribution, alongside recurring health and genealogy subscriptions.
How is the market structured across products and applications?
Consumer genomics products span ancestry and genetic relatedness, health-risk and diagnostic reports, sports nutrition, nutrition and wellness, and pharmacogenomic applications. Genetic relatedness had a 19.8% revenue share in 2022 in Grand View Research’s latest publicly available breakdown.
What compliance requirements affect direct-to-consumer tests?
In the United States, the FDA requires direct-to-consumer tests to be analytically valid, clinically valid and appropriate for use without a healthcare professional when applicable. MedlinePlus advises consumer results generally require confirmation through additional provider-ordered testing before diagnostic or treatment decisions are made.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 19). Consumer Genomics Industry Statistics. Gitnux. https://gitnux.org/consumer-genomics-industry-statistics
MLA
Samuel Norberg. "Consumer Genomics Industry Statistics." Gitnux, 19 Nov 2026, https://gitnux.org/consumer-genomics-industry-statistics.
Chicago
Samuel Norberg. 2026. "Consumer Genomics Industry Statistics." Gitnux. https://gitnux.org/consumer-genomics-industry-statistics.